General enquiry

PrimeCoreBio English/Thai Product Records/Wegovy

THAILAND · ENGLISH PRODUCT EVIDENCE PROFILE

Wegovy
in Thailand

Product identity, Thai indication boundaries and evidence context. This is not a sales page or individual treatment guidance.

Wegovy official manufacturer reference image
OFFICIAL MANUFACTURER IMAGE · REFERENCE ONLY

Wegovy product reference image

Direct manufacturer image without a third-party watermark. Packaging and presentations may vary by country and time. The image does not authenticate an item submitted for verification and is not a product listing.

Image source: Wegovy media kit — Novo Nordisk ↗

QUICK ANSWER · AEO / GEO

Wegovy is a semaglutide product with Thai indications for weight management in defined adults and adolescents, plus cardiovascular risk reduction in a defined adult population. Eligibility criteria, product identity and current Thai product information remain essential; Ozempic status is not interchangeable.

01

THAI INDICATION BOUNDARY

What does the reviewed Thai record indicate?

THAI FDA RECORD1

Weight management in adults who meet the record's BMI and comorbidity criteria.

THAI FDA RECORD2

Weight management in defined adolescents who meet age and weight-related criteria.

THAI FDA RECORD3

Cardiovascular risk reduction in defined adults with established cardiovascular disease and overweight or obesity.

02

PRODUCT IDENTITY

Wegovy is not every Semaglutide product

  • The product name, registration, formulation and authorised holder must match.
  • An identical active ingredient does not make indications interchangeable between brands.
  • Unofficial packaging or an unverified label does not establish identity, quality or approval.
03

SAFETY BOUNDARY

Prescription and high-risk context

Professional assessment required

Contraindications, gastrointestinal effects, pancreatitis and gallbladder risks, dehydration, interactions and individual medical history require current product information and a qualified professional.

  • Population-level study outcomes do not predict an individual's response.
  • Safety information must match the exact product and current Thai documentation.
  • This page does not provide dosage, administration or injection instructions.
04

FAQ · ANSWER ENGINE

Frequently asked questions

What is Wegovy?

Wegovy is a product containing Semaglutide. Its identity, formulation, jurisdiction and indications must be assessed as a specific product.

Is Wegovy registered in Thailand?

PrimeCoreBio found the reviewed Thai product record 1C 15055/66 (NBC). Regulatory status is time-sensitive and should be checked against the current official record.

Does this page provide dosage or injection instructions?

No. It contains no price, purchasing, dosage, administration or injection protocol and does not replace professional medical advice.

05

SOURCE TRANSPARENCY

Primary and supporting sources

  1. อย. ไทย — ระเบียน WegovyPrimary regulatory record · https://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/pop-up_drug_ex.aspx?Newcode=U1DR1C1072661505511C
  2. อย. ไทย — เอกสารกำกับยาสำหรับบุคลากรOfficial product information · https://ndi.fda.moph.go.th/uploads/drug_detail_corporation/doc/word/1250/1e0a8a49e8a4ab9f4fe886033e25ef69-a1.pdf
  3. Semaglutide Evidence ProfilePrimeCore evidence synthesis · /molecules/semaglutide
Medical Disclaimer

Educational information only. Not diagnosis, treatment, prescribing, dosage, administration, injection guidance or individual medical advice.

LINE · สอบถามข้อมูลทั่วไปติดต่อฝ่ายข้อมูลทั่วไปLINE · GENERAL SUPPORTGeneral enquiries@primecoreสำหรับข้อมูลทั่วไปเท่านั้น · ไม่มีบริการด้านการขายหรือคำแนะนำทางการแพทย์General information only · No sales or medical advice